- Home
- BTBT vs RLAY Comparison
BTBT vs RLAY Comparison
Compare BTBT & RLAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BTBT | RLAY |
|---|---|---|
| Founded | 2015 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.3B |
| IPO Year | 2018 | 2020 |
Fundamental Metrics
Financial Performance| Metric | BTBT | RLAY |
|---|---|---|
| Price | $2.08 | $8.23 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 7 |
| Target Price | $6.50 | ★ $16.00 |
| AVG Volume (30 Days) | ★ 33.8M | 2.1M |
| Earning Date | 11-14-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.62 | N/A |
| Revenue | ★ $105,703,143.00 | $8,355,000.00 |
| Revenue This Year | $7.04 | $20.47 |
| Revenue Next Year | $96.28 | N/A |
| P/E Ratio | $3.17 | ★ N/A |
| Revenue Growth | ★ 7.86 | N/A |
| 52 Week Low | $1.69 | $1.78 |
| 52 Week High | $4.55 | $9.04 |
Technical Indicators
Market Signals| Indicator | BTBT | RLAY |
|---|---|---|
| Relative Strength Index (RSI) | 39.73 | 62.38 |
| Support Level | $1.95 | $7.95 |
| Resistance Level | $2.19 | $9.04 |
| Average True Range (ATR) | 0.17 | 0.48 |
| MACD | 0.01 | 0.02 |
| Stochastic Oscillator | 29.25 | 60.22 |
Price Performance
Historical ComparisonAbout BTBT Bit Digital Inc.
Bit Digital Inc is engaged in the Bitcoin mining business, Ethereum staking activities and specialized cloud-infrastructure services for artificial intelligence applications through its wholly owned subsidiaries. Its mining platform operates with the primary intent of accumulating bitcoin which may sell for fiat currency from time to time depending on market conditions. The Company has four reportable segments: digital asset mining, cloud services, colocation services, and ETH Staking. It generates majority of its revenue from digital asset mining.
About RLAY Relay Therapeutics Inc.
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).